This week's Fierce Biotech is brought to you by Absci.

Trouble viewing? Click here.

Connect with us at BIO International!

Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.

Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic, engineer-in "best-in-class properties", drug difficult targets, and access novel biology. Learn more about our science here:

• Unlocking de novo antibody design with generative artificial intelligence
• In vitro validated antibody design against multiple therapeutic antigens using generative inverse folding
• Scaling data and AI for multioptimized biologics

We invite you to meet us at the BIO International conference coming up June 3-6 in San Diego to discuss how we can work together to create better biologics for patients, faster.

Connect with us at BIO

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.

You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor  
New York, NY 10017